Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $12.7900 (-1.39%) ($12.3900 - $13.2900) on Thu. Sep. 3, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.47% (three month average) | RSI | 58 | Latest Price | $12.7900(-1.39%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -0.7% a day on average for past five trading days. | Weekly Trend | ATRA advances 2.2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(44%) IBB(44%) ARKK(43%) IWO(43%) | Factors Impacting ATRA price | ATRA will decline at least -2.235% in a week (0% probabilities). VIXM(-32%) VXX(-27%) UNG(-10%) UUP(-9%) TLT(-7%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.235% (StdDev 4.47%) | Hourly BBV | 0 () | Intraday Trend | -0.3% | | | |
|
Resistance Level | $12.87 | 5 Day Moving Average | $13.15(-2.74%) | 10 Day Moving Average | $13.15(-2.74%) | 20 Day Moving Average | $12.87(-0.62%) | To recent high | -17.5% | To recent low | 43.1% | Market Cap | $950m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |